Trial intelligence / Profile preview

Chondrogen for Meniscal Regeneration

NCT00225095Phase 2Completed

Sponsor
Mesoblast Ltd
Start
Sep 2005
Primary completion
Apr 2008
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of Chondrogen in meniscal tear, sponsored by Mesoblast Ltd. Started Sep 2005; status: completed.

02

Drugs

Chondrogen
03

Conditions

meniscal tear

Beyond the preview

Go deeper on NCT00225095.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00225095.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call